Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Senate Finance Committee Proposes Including “Authorized” Generics In “Best Price”

This article was originally published in The Pink Sheet Daily

Executive Summary

Chairman Grassley’s budget reconciliation proposal, which will be voted on by the committee on Oct. 24, also increases minimum manufacturer rebates paid to the Medicaid program.

You may also be interested in...



Budget Reconciliation Bill Will Yield Savings From Medicaid Prescription Drug Reform

The Deficit Reduction Act of 2005 projects $4.76 bil. in savings from Medicaid between 2006 and 2010, including $3.86 bil. from prescription drug payment reform.

Budget Reconciliation Bill Will Yield Savings From Medicaid Prescription Drug Reform

The Deficit Reduction Act of 2005 projects $4.76 bil. in savings from Medicaid between 2006 and 2010, including $3.86 bil. from prescription drug payment reform.

Senate Finance Committee Approves Increased Generic Manufacturer Rebates

The Medicaid reform provision was marked up within budget reconciliation legislation that otherwise remained unchanged.

Related Content

Topics

UsernamePublicRestriction

Register

PS061132

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel